Clinical Trial Update: Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating the combination of Adcetris and Levact for Hodgkin lymphoma in older patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)
• Levact (liposomal daunorubicin)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Clinical Efficacy, Safety | Phase 1, Phase 2 | Status: COMPLETED